Skip to main content
eScholarship
Open Access Publications from the University of California

Scholarly Works (5 results)

  • Article
  • Peer Reviewed
Dermatology Online Journal, Volume 21, Issue 3 (2015)

Abstract

Background: The Maintenance of Certification (MOC) program proposed by the American Board of Medical Specialties (ABMS) gained approval in 2006. The implementation of this program will impact all physicians who are board certified. Therefore, The Financial Status of the Medical Boards is an increasingly relevant topic of discussion amongst all physicians and those interested in medical education and certification. With this study we aim to bring greater attention to the already publicly available financial status of the Medical Boards (MB) so that it can become part of the ongoing discussion of MOC.

Method: We analyzed the yearly revenue, expenses, net gain or loss and end of year balance for the ABMS and its 24 MB, additional member boards, as well as the Accreditation Council for Graduate Medical Education (ACGME), American Osteopathic Association (AOA) and Accreditation Council for Continuing Medical Education (ACCME) organizations.

Results: We have commented on notable trends based on the available IRS Form 990s spanning from 1997 to 2012. When comparing the most recently available reported end of year balance to the first available reported end of year balance, 87% (27/31) of the member boards have reported an increase. All three of the additional organizations studied, ACGME, AOA and ACCME reported an increase as well.

Conclusions: It is clear from the data and analysis that the majority of MB have financially benefited from the MOC program. It remains to be proven whether or not this economic benefit will translate into an improvement in physician education and patient care.

    Cover page: Maintenance of certification and the financial status of the medical boardsCreative Commons 'BY-NC-ND' version 4.0 license
    • Article
    Dermatology Online Journal, Volume 26, Issue 1 (2020)
    Medical board organizations have accumulated large asset balances, in part due to the monetization of physician board recertification, as well as capital gains in positive investment conditions. Physicians across the country have raised concerns regarding the effectiveness and efficiency of existing recertification processes, to which the American Board of Medical Specialties and independent accreditation boards have responded with newly instituted changes. The present article analyzes the publicly available F990 tax forms of the medical boards in an effort to provide data to the ongoing debate. Although some boards have begun to mobilize assets in recent years, many continue to accumulate wealth. It remains to be seen whether the new recertification programs will bring about change or perpetuate organizational wealth.
      Cover page: The evolving maintenance of certification process: update on the financial status of the medical boardsCreative Commons 'BY-NC-ND' version 4.0 license
      • Article
      • Peer Reviewed
      Dermatology Online Journal, Volume 21, Issue 2 (2015)

      Anti-tumor necrosis factor induced lupus (ATIL) is a rare side effect reported in patients treated with anti-tumor necrosis factor medications such as infliximab, etanercept and adalimumab. Of the three, this condition has been least commonly reported secondary to adalimumab. In this report, we present a case of ATIL in a patient treated for rheumatoid arthritis (RA) with adalimumab. This report will increase physician awareness of the warning signs, diagnostic options and potential complications of ATIL. In this patient, adalimumab was discontinued and treatment was started, leading to improvement in the patient’s status.

      • 7 supplemental images
      Cover page: TNF-inhibitor induced Lupus in a patient treated with adalimumab for rheumatoid arthritisCreative Commons 'BY-NC-ND' version 4.0 license
      • Article
      LBL Publications (1955)
        Cover page: NUCLEOPROTEIN FRACTIONS FROM VARIOUS EMBRYONIC TISSUES A COMPARISON OF PHYSIOCOCHEMICAL CHARACTERISTICS AND BIOLOGICAL ACTIVITY IN TISSUE CULTURE
        • Article
        • Peer Reviewed
        Dermatology Online Journal, Volume 22, Issue 3 (2016)
        Pemphigus foliaceus (PF) is a sporadic autoimmune blistering disease of unknown etiology. The production of immunoglobulin G4 antibodies against desmoglein-1 is responsible for the clinical manifestation of PF. We present a case of a woman with a recent diagnosis of myasthenia gravis (MG), who was also recently treated with radiation therapy for breast cancer. The clinical exam, supported by biopsy and direct immunofluorescence, were consistent with PF. We present this case to increase the awareness of the potential exacerbation or induction of PF with radiation, and of the association of PF and myasthenia gravis. Only five prior cases of radiation-exacerbated or radiation-induced PF have been reported in the literature to date. Furthermore, the co-existence of the autoimmune entities of myasthenia gravis and PF has been reported in the literature in only 9 cases and was also noted in this patient.
          Cover page: Pemphigus foliaceus exacerbated by radiation, in association with myasthenia gravisCreative Commons 'BY-NC-ND' version 4.0 license
          Top